Doliver Advisors LP Decreases Stock Position in CVS Health Co. (NYSE:CVS)

Doliver Advisors LP trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 21.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,126 shares of the pharmacy operator’s stock after selling 1,434 shares during the period. Doliver Advisors LP’s holdings in CVS Health were worth $230,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CVS. Central Pacific Bank Trust Division boosted its position in shares of CVS Health by 3.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 34,257 shares of the pharmacy operator’s stock valued at $1,538,000 after buying an additional 989 shares during the last quarter. Principal Financial Group Inc. lifted its stake in CVS Health by 4.8% during the 3rd quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator’s stock valued at $90,200,000 after acquiring an additional 66,244 shares during the period. Old North State Trust LLC purchased a new stake in shares of CVS Health during the 3rd quarter valued at about $200,000. Tidal Investments LLC grew its stake in shares of CVS Health by 52.2% in the third quarter. Tidal Investments LLC now owns 112,010 shares of the pharmacy operator’s stock worth $7,043,000 after acquiring an additional 38,408 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new position in CVS Health during the third quarter valued at approximately $2,071,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.1 %

NYSE CVS opened at $45.82 on Tuesday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $83.25. The stock’s 50 day moving average is $52.63 and its 200 day moving average is $56.97. The stock has a market cap of $57.66 billion, a PE ratio of 11.63, a P/E/G ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 earnings per share. Research analysts predict that CVS Health Co. will post 5.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.81%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s payout ratio is presently 67.51%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research note on Tuesday, December 3rd. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Finally, UBS Group raised their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.